1. Home
  2. CPRX

CPRX

Catalyst Pharmaceuticals Inc.

Logo Catalyst Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 10:50am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Founded: 2002 Country:
United States
United States
Employees: N/A City: CORAL GABLES
Market Cap: 1.8B IPO Year: 2006
Target Price: $26.83 AVG Volume (30 days): 1.3M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.63 EPS Growth: -16.00
52 Week Low/High: $11.09 - $18.22 Next Earning Date: 05-08-2024
Revenue: $398,204,000 Revenue Growth: 85.90%
Revenue Growth (this year): 18.77% Revenue Growth (next year): 19.26%

Share on Social Networks: